Benzinga | Nov 4, 2021 08:14AM EDT

NeoGenomics Q3 EPS $(0.08) Beats $(0.09) Estimate, Sales $121.34M Miss $125.05M Estimate

NeoGenomics (NASDAQ:NEO) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.09) by 11.11 percent. This is a 233.33 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $121.34 million which missed the analyst consensus estimate of $125.05 million by 2.97 percent. This is a 3.27 percent decrease over sales of $125.44 million the same period last year.